Bevorzugter Name 4-Ethyl-N-(4-(1-(tetrahydro-2H-pyran-4-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl)pyridin-2-yl)piperazine-1-carboxamide
IUPAC 4-ethyl-N-[4-[1-(oxan-4-yl)pyrrolo[2,3-c]pyridin-3-yl]-2-pyridinyl]piperazine-1-carboxamide
Englischer Name 1-Piperazinecarboxamide, 4-ethyl-N-[4-[1-(tetrahydro-2H-pyran-4-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-2-pyridinyl]-
Summenformel C24H30N6O2
Molmasse 434.53 Namen und Synonyme GNF2133 2561414-56-8 4-Ethyl-N-(4-(1-(tetrahydro-2H-pyran-4-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl)pyridin-2-yl)piperazine-1-carboxamide 4-ethyl-N-{4-[1-(oxan-4-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]pyridin-2-yl}piperazine-1-carboxamide CHEMBL4636064 GTPL10687 GNF-2133 4-ethyl-N-[4-[1-(oxan-4-yl)pyrrolo[2,3-c]pyridin-3-yl]pyridin-2-yl]piperazine-1-carboxamide orb1303298 SCHEMBL30196671 GLXC-23801 EX-A6080
Weitere Namen anzeigen 1-Piperazinecarboxamide, 4-ethyl-N-[4-[1-(tetrahydro-2H-pyran-4-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-2-pyridinyl]- β-cell,RIP-DTA mice,Inhibitor,insulin secretion,GNF2133,inhibit,Dual specificity tyrosine regulated kinase,glucose disposal,Dual specificity tyrosine phosphorylation regulated kinase,CD-1 mice,GNF 2133,DYRK,GNF-2133,orally active
GNF2133, 10 mM in DMSO GNF2133? BDBM50538099 MFCD34676630 AKOS040757848 compound 13g [PMID: 32077280] DA-53663 MS-27785
Mehr laden (20 angezeigt)